With more vaccines than vaccinations, India exports Covishield before expiry date
It is true that while the U.S. took 10 days to breach the one-million mark and the U.K. took 18 days, India took only six days. The number of people…
Author: Prasad Ravindranath
Science Editor with @The_Hindu, Chennai, India.
Do get in touch with me at PRASAD.THEHINDU@GMAIL.COM if you have some interesting results that can be published in The Hindu and also in my blog. You can also reach me on Twitter @RPrasad12 and Facebook /prasad.ravindranath.
I write on science, health, medicine, environment, and technology.
Study finds Covaxin effective against the UK variant
The sera from people vaccinated with Covaxin were tested against the same strain used for making the vaccine, another strain found in India but different from the one used for…
Glitches in CoWIN also responsible for low COVID-19 vaccine uptake
On January 16, the first day of COVID-19 vaccination in the country, at about only 1.91 lakh health-care workers taking the jab, only about two-third of the eligible people were…
Indian scientists divided over restricted use approval for Covaxin
In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement…
Vaccine dilemma: To take or not to take Covaxin
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…
Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial
The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of Medical Sciences & Research Centre appears to suffer from serious…
New challenges in conducting COVID-19 vaccine trials in India
The Ahmedabad-based Zydus Cadilla only recently got the regulatory permission to carry out phase-3 trial and has to begin the recruitment, while the Hyderabad-based Biological E is yet to reach…
I would not take Covaxin without efficacy data: Gagandeep Kang
Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…
